124 related articles for article (PubMed ID: 23042366)
1. Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis.
de Nigris F; Mancini FP; Schiano C; Infante T; Zullo A; Minucci PB; Al-Omran M; Giordano A; Napoli C
J Cell Physiol; 2013 Apr; 228(4):846-52. PubMed ID: 23042366
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.
de Nigris F; Rossiello R; Schiano C; Arra C; Williams-Ignarro S; Barbieri A; Lanza A; Balestrieri A; Giuliano MT; Ignarro LJ; Napoli C
Cancer Res; 2008 Mar; 68(6):1797-808. PubMed ID: 18339860
[TBL] [Abstract][Full Text] [Related]
4. Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells.
Vella S; Tavanti E; Hattinger CM; Fanelli M; Versteeg R; Koster J; Picci P; Serra M
PLoS One; 2016; 11(11):e0166233. PubMed ID: 27898692
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.
Liebl J; Krystof V; Vereb G; Takács L; Strnad M; Pechan P; Havlicek L; Zatloukal M; Fürst R; Vollmar AM; Zahler S
Angiogenesis; 2011 Sep; 14(3):281-91. PubMed ID: 21487803
[TBL] [Abstract][Full Text] [Related]
6. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
7. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
8. Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5.
Sharma MR; Tuszynski GP; Sharma MC
J Cell Biochem; 2004 Feb; 91(2):398-409. PubMed ID: 14743398
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.
Liebl J; Weitensteiner SB; Vereb G; Takács L; Fürst R; Vollmar AM; Zahler S
J Biol Chem; 2010 Nov; 285(46):35932-43. PubMed ID: 20826806
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Kumanishi S; Yamanegi K; Nishiura H; Fujihara Y; Kobayashi K; Nakasho K; Futani H; Yoshiya S
Int J Oncol; 2019 Jul; 55(1):167-178. PubMed ID: 31180533
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
Wan D; Jiang C; Hua X; Wang T; Chai Y
Anticancer Drugs; 2015 Oct; 26(9):931-41. PubMed ID: 26181229
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
Qiu R; Ma G; Zheng C; Qiu X; Li X; Li X; Mo J; Li Z; Liu Y; Mo L; Bi G; Ye Y
Exp Mol Pathol; 2014 Aug; 97(1):17-22. PubMed ID: 24797937
[TBL] [Abstract][Full Text] [Related]
14. The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line.
Kuo HS; Hsu FN; Chiang MC; You SC; Chen MC; Lo MJ; Lin H
Chin J Physiol; 2009 Feb; 52(1):23-30. PubMed ID: 19764350
[TBL] [Abstract][Full Text] [Related]
15. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
Ek ET; Dass CR; Contreras KG; Choong PF
J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
[TBL] [Abstract][Full Text] [Related]
16. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
17. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
Wang Y; Fu Q; Zhao W
Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
[TBL] [Abstract][Full Text] [Related]
19. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
20. Growth factors, their receptor expression and markers for proliferation of endothelial and neoplastic cells in human osteosarcoma.
Bianchi E; Artico M; Di Cristofano C; Leopizzi M; Taurone S; Pucci M; Gobbi P; Mignini F; Petrozza V; Pindinello I; Conconi MT; Della Rocca C
Int J Immunopathol Pharmacol; 2013; 26(3):621-32. PubMed ID: 24067459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
